Moody’s downgrades Amprion’s credit rating to “Baa2” and revises outlook to “stable”
Moody’s downgrades Amprion’s credit rating to “Baa2” and revises outlook to “stable” Amprion
Finance, IT & News
Moody’s downgrades Amprion’s credit rating to “Baa2” and revises outlook to “stable” Amprion
Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher Arrowhead Pharmaceuticals, Inc.
Antitrust Trial Over Paramount-Warner Merger Set for March WSJ
Tensions flare as public defender strike heads into second week Queens Daily Eagle
Tech companies chop several hundred Bay Area jobs in fresh layoffs The Mercury News